Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

846998

registered interest
date	22/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether a decision has been reached on the sensitivity threshold for the faecal immunochemical test when it is introduced into the bowel cancer screening programme due to be implemented in April 2018; and if he will make a statement.
tabling member constituency	Eastbourne
tabling member printed	Stephen Lloyd
uin	129172
answer	answer is ministerial correction date of answer 28/02/2018 answer text <p>A decision is expected to be made in 2018/19 on the sensitivity threshold for the faecal immunochemical test (FIT) on its introduction to the bowel cancer screening programme.</p><p> </p><p>NHS England remains committed to the implementation of FIT testing within the NHS Bowel Cancer Screening Programme from 2018. During 2018, NHS England will finalise a number of practical steps to ensure when FIT is implemented it is sustainable. These steps include: working with Public Health England who will be ensuring that the practical arrangements for managing the production and distribution of FIT kits are in place and working with local providers to ensure sufficient workforce capacity is in place to deliver FIT and save lives.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/02/2018 14:45:19 answering member 4067 label Biography information for Steve Brine
tabling member	3968 label Biography information for Stephen Lloyd

845539

registered interest
date	20/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the publication of the decision on the preferred supplier for the faecal immunochemical test kit tender award within the bowel cancer screening programme.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	128511
answer	answer is ministerial correction date of answer 28/02/2018 answer text <p>Public Health England has, on behalf of the five bowel cancer screening hubs in England, led on the procurement of the kit to support the implementation of the faecal immunochemical test in the bowel cancer screening programme in England.</p><p> </p><p>Work is now progressing on the process to complete the procurement requirements in order to allow delivery of the kit and other aspects of the service related to the kit.</p><p> </p><p>The supplier will be announced once agreement is in place following the completion of the procurement process in spring 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/02/2018 13:08:31 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

845652

registered interest
date	20/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps the Government is taking to ensure that funding is appropriately allocated to test all people with bowel cancer for molecular features of Lynch syndrome in accordance with NICE guidance, DG27, published in February 2017.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	128624
answer	answer is ministerial correction date of answer 28/02/2018 answer text <p>The commissioning of services for people diagnosed with Lynch Syndrome, including surveillance, generally sits with clinical commissioning groups (CCGs). CCGs are best placed to commission services to meet the needs of local populations, taking into account the best available evidence.</p><p> </p><p>Testing for Lynch syndrome in people with colorectal cancer is targeted using criteria based on family history and age of cancer onset to determine people at higher risk. New National Institute for Health and Care Excellence (NICE) diagnostic guidance recommends extending this offer to all people with colorectal cancer when they are first diagnosed. Offering tests to all people with colorectal cancer will need to be considered by NHS England as part of its service development process.</p><p> </p><p>Each year, a number of new drugs, medical devices, tests and treatments in specialised services are put forward to NHS England. The promising proposals are considered by experts in the field, including doctors, public health experts and lay people. These groups, established by NHS England, are known as Clinical Reference Groups (CRGs). The CRGs make detailed assessments of the new treatments, tests and devices through Policy Working Groups and make recommendations on their potential adoption in the NHS.</p><p> </p><p>The Medical Genetics CRG will consider the NICE diagnostic guidance and have been asked to submit a Preliminary Policy Proposal and to identify a Clinical Lead to oversee the development of the proposal.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 128627 question first answered 28/02/2018 13:11:28 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

845655

registered interest
date	20/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, which body is responsible for the governance and funding of testing for molecular features of Lynch syndrome in all people diagnosed with bowel cancer in accordance with NICE guidance, DG27, published in February 2017; and if he will make a statement.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	128627
answer	answer is ministerial correction date of answer 28/02/2018 answer text <p>The commissioning of services for people diagnosed with Lynch Syndrome, including surveillance, generally sits with clinical commissioning groups (CCGs). CCGs are best placed to commission services to meet the needs of local populations, taking into account the best available evidence.</p><p> </p><p>Testing for Lynch syndrome in people with colorectal cancer is targeted using criteria based on family history and age of cancer onset to determine people at higher risk. New National Institute for Health and Care Excellence (NICE) diagnostic guidance recommends extending this offer to all people with colorectal cancer when they are first diagnosed. Offering tests to all people with colorectal cancer will need to be considered by NHS England as part of its service development process.</p><p> </p><p>Each year, a number of new drugs, medical devices, tests and treatments in specialised services are put forward to NHS England. The promising proposals are considered by experts in the field, including doctors, public health experts and lay people. These groups, established by NHS England, are known as Clinical Reference Groups (CRGs). The CRGs make detailed assessments of the new treatments, tests and devices through Policy Working Groups and make recommendations on their potential adoption in the NHS.</p><p> </p><p>The Medical Genetics CRG will consider the NICE diagnostic guidance and have been asked to submit a Preliminary Policy Proposal and to identify a Clinical Lead to oversee the development of the proposal.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 128624 question first answered 28/02/2018 13:11:28 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

839266

registered interest
date	08/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timescale is for the introduction of the Faecal Immunochemical Test to the bowel screening programme.
tabling member constituency	Bristol East
tabling member printed	Kerry McCarthy
uin	127820
answer	answer is ministerial correction date of answer 23/02/2018 answer text <p>NHS England remains committed to the implementation of Faecal Immunochemical Test (FIT) within the NHS Bowel Cancer Screening Programme from 2018.</p><p> </p><p>During 2018, NHS England will finalise a number of practical steps to ensure that when Faecal Immunochemical Test is implemented, it is sustainable. This includes working with Public Health England, who will be ensuring that the practical arrangements for managing the production and distribution of FIT kits are in place, and working with local providers to ensure sufficient workforce capacity is in place to deliver FIT and save lives. These practical steps will enable NHS England to confirm the specific date in 2018 when FIT will replace Faecal Occult Blood testing.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/02/2018 12:55:43 answering member 4067 label Biography information for Steve Brine
tabling member	1491 label Biography information for Kerry McCarthy

828024

registered interest
date	22/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has plans to reduce the bowel cancer screening age; and if he will make a statement.
tabling member constituency	Mitcham and Morden
tabling member printed	Siobhain McDonagh
uin	123984
answer	answer is ministerial correction date of answer 30/01/2018 answer text <p>Using existing evidence and modelling techniques the United Kingdom National Screening Committee (UKNSC) is currently consulting on changes to the current bowel screening programme - whether bowel scope and Faecal Immunochemical Testing (FIT) can be offered as a combination or if FIT is robust enough to be the primary screen test from the age of 50 years.</p><p> </p><p>The three month consultation closes on 7 April with a recommendation at a subsequent meeting. Information about the consultation and how to participate is available at:</p><p><a href="https://legacyscreening.phe.org.uk/bowelcancer" target="_blank">https://legacyscreening.phe.org.uk/bowelcancer</a></p><p> </p><p>If any changes are to be made to an existing screening programme this will follow the UK NSC’s published evidence review process which can be viewed at:</p><p> </p><p><a href="https://www.gov.uk/government/publications/uk-nsc-evidence-review-process" target="_blank">https://www.gov.uk/government/publications/uk-nsc-evidence-review-process</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/01/2018 14:27:14 answering member 4067 label Biography information for Steve Brine
tabling member	193 label Biography information for Dame Siobhain McDonagh

806112

registered interest
date	13/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether his Department has plans to reduce the screening age for bowel cancer to 50 years old.
tabling member constituency	Bristol East
tabling member printed	Kerry McCarthy
uin	119313
answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>Following the Ministerial approval of the United Kingdom National Screening Committee’s (UK NSC’s) recommendation to introduce Faecal Immunochemical Testing as the primary screen test in the NHS Bowel Cancer Screening Programme, the UK NSC commissioned the Sheffield School of Health and Related Research (ScHARR) to use existing evidence and modelling techniques to describe options for optimising bowel cancer screening. This includes at different cut off levels for the test and at various age ranges.</p><p> </p><p>The UK NSC will continue to work with ScHARR, and stakeholders, and will make a final recommendation in 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 16:24:21 answering member 4067 label Biography information for Steve Brine
tabling member	1491 label Biography information for Kerry McCarthy

803047

registered interest
date	08/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Bowel Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they intend to offer screening for bowel cancer to all over 45s.
tabling member printed	Baroness Redfern
uin	HL4012
answer	answer is ministerial correction date of answer 20/12/2017 answer text <p>Following Ministerial approval of the United Kingdom National Screening Committee’s (UK NSC) recommendation to introduce Faecal Immunochemical Testing as the primary screen test in the National Health Service Bowel Cancer Screening Programme, the UK NSC commissioned the Sheffield School of Health and Related Research (ScHARR) to use existing evidence and modelling techniques to describe options for optimising bowel cancer screening. This includes different cut off levels for the test and various age ranges.</p><p> </p><p>The UK NSC will continue to work with ScHARR and stakeholders, and will make a final recommendation in 2018.</p><p> </p> answering member printed Lord O'Shaughnessy question first answered 20/12/2017 13:48:41 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	4551 label Biography information for Baroness Redfern

798066

registered interest
date	30/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Bowel Cancer: Screening
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they have plans to make colonoscopies available through the NHS as a method of screening for pre-symptomatic cancers.
tabling member printed	Lord Crathorne
uin	HL3762
answer	answer is ministerial correction date of answer 14/12/2017 answer text <p>Colonoscopy is currently used in the National Health Service bowel cancer screening programme as a diagnostic tool to look at the bowel following a positive screen test for bowel cancer and to remove any polyps (growths) if detected.</p><p> </p><p>The aim of a screening programme is to offer a safe and simple test to a large defined population who are at an average risk of developing the condition and to provide early intervention. Colonoscopy is an invasive procedure which in some cases can cause bleeding and discomfort and does not meet the United Kingdom National Screening Committee’s test criteria as noted.</p> answering member printed Lord O'Shaughnessy question first answered 14/12/2017 11:36:10 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	3380 label Biography information for Lord Crathorne

786845

registered interest
date	10/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to increase GP training to improve the detection of bowel cancer.
tabling member constituency	Chippenham
tabling member printed	Michelle Donelan
uin	112382
answer	answer is ministerial correction date of answer 20/11/2017 answer text <p>The standard of medical training is the responsibility of the General Medical Council (GMC), which is an independent statutory body. The GMC has the general function of promoting high standards of education and co-ordinating all stages of education to ensure that medical students and newly qualified doctors are equipped with the knowledge, skills and attitudes essential for professional practice. Continuing professional and personal development for registered professionals employed in the National Health Service is a matter for employers and those individuals.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/11/2017 12:26:31 answering member 4067 label Biography information for Steve Brine
tabling member	4530 label Biography information for Michelle Donelan